Masamichi Sugimoto

4PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 25, 2026
Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve Egfr-Mutant Lung Cancer with Non-Inflamed Tumor Microenvironment.

|Nov 19, 2021
PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8+ T cells in hematogenous metastasis model with lymphocyte infusion.

Chinami Masuda, Mamiko Morinaga, Daiko Wakita

|Jan 28, 2021
Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.

Tania Afroj, Atsushi Mitsuhashi, Hirokazu Ogino

|Nov 27, 2019
Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model.

Chinami Masuda, Masamichi Sugimoto, Daiko Wakita

Pageof 1

Frequent Collaborators

1 joint publications

Tania Afroj

1 joint publications

Atsushi Mitsuhashi

1 joint publications

Hirokazu Ogino

1 joint publications

Atsuro Saijo